INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

Graham Capital Management, L.P.'s Holding History (CIK: 0001315421)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 13,500,000 Value ($000) $10,935 Avg Close — Range —
Q2 2020
Shares 18,000,000 Value ($000) $13,479 Avg Close — Range —
Q1 2020
Shares 18,000,000 Value ($000) $14,732 Avg Close — Range —
Q4 2019
Shares 16,000,000 Value ($000) $16,205 Avg Close — Range —
Q3 2019
Shares 16,000,000 Value ($000) $13,775 Avg Close — Range —
Q2 2019
Shares 16,000,000 Value ($000) $14,420 Avg Close — Range —
Q1 2019
Shares 12,000,000 Value ($000) $11,895 Avg Close — Range —
Q4 2018
Shares 14,636,000 Value ($000) $13,509 Avg Close — Range —
Q3 2018
Shares 14,636,000 Value ($000) $14,768 Avg Close — Range —
Q2 2018
Shares 13,636,000 Value ($000) $11,946 Avg Close — Range —
Q1 2018
Shares 12,956,000 Value ($000) $10,398 Avg Close — Range —
Q4 2017
Shares 12,956,000 Value ($000) $10,348 Avg Close — Range —